Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
SUBSCRIBE FOR FREE
Twitter
Cancerworld Magazine
Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
Cancerworld Magazine > News > Cancer caused by occupational exposure needs urgent attention
  • News

Cancer caused by occupational exposure needs urgent attention

  • 10 March 2021
  • Valéria Hartt
Cancer caused by occupational exposure needs urgent attention
Total
0
Shares
0
0
0
0
0

What is the cancer burden associated with occupational exposure? A new review shows that the question needs urgent attention, given under-reporting and current difficulties in estimating the global burden.

The review, in Molecular Oncology, highlights how millions of workers are exposed daily to crystalline silica in mineral dust, diesel engine exhaust emissions, welding fumes and wood dust.

“If employers are successful in controlling exposure in the workplace, the fraction of lung cancer attributable to occupational exposure would be reduced dramatically”, say the authors, from the International Agency for Research on Cancer (IARC) and the Institute for Risk Assessment Sciences, Utrecht University.

They review studies that use the “population attributable fractions” metric to estimate the proportion of cases that would have occurred if exposure had not been present. Together, exposure to crystalline silica, diesel engine exhaust emissions and welding fumes account for half of the occupational PAF for lung cancer, they say.

Lung cancer is the most prevalent occupational cancer, with an estimated PAF between 18 and 25% in the male population, followed by mesothelioma and bladder cancer. National studies in the United Kingdom, France and Canada suggest that nasopharyngeal tumours and non-melanoma skin cancers (NMSC) are also among the top five occupational cancers.

The publication reports the association between nasopharyngeal tumours and exposure to wood dust and formaldehyde, as well as non-melanoma skin cancers (NMSCs) in workers exposed to solar radiation and substances such as coal tars and pitches, mineral oils and arsenic.

It highlights possible variations due to differences in the manufacturing and composition of different materials. The composition of organic dust can vary dramatically when working with different moisture levels, and exposure to substances generated by combustion can also vary according to where the emission takes place (surface or underground mining, for example) and type and age of engine.

Another warning is that many occupational exposures have a larger effect on smokers. An analysis (the SYNERGY Project) of the interaction between smoking and exposure to occupational lung carcinogens showed the effect of both exposures exceeded the sum of each individually.

According to the World Health Organization (WHO), there were 472,124 deaths attributable to occupational cancer in 2018, equivalent to 53% of the total deaths due to work-related chronic diseases. Nevertheless, the numbers could be a major underestimate.
“The prevalence of process-generated substances in the majority of countries, including low-and middle-income countries, is largely unknown, because few studies have been conducted locally”, say the authors, Ann Olsson, epidemiologist at IARC and Hans Kromhout from Utrecht University.

Limited available data means that PAFs, criteria for defining prevalence of occupational cancers and levels of exposure are not easily comparable in studies. Methodological differences also call into question the sensitivity of occupational exposure estimates, say the authors.

Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Related Topics
  • Lung cancer
  • occupational cancer
Valéria Hartt

Valéria Hartt is a journalist focused on cancer coverage, master’s in science by Oswaldo Cruz Foundation (FIOCRUZ), the most prominent institution of science and technology in health in Latin America, founder and director of Onconews, a leading media about Oncology in Portuguese language.

Previous Article
  • News

European vision for universal access to oncology precision medicine biomarker tests

  • 8 March 2021
  • Janet Fricker
View Post
Next Article
  • Articles
  • Delivery of Care

Our pathways: advocates provide roadmaps for patients, clinicians and managers

  • 11 March 2021
  • Simon Crompton
View Post
You May Also Like
View Post
  • News

Key link identified in mechanism promoting lung metastases from breast cancer

  • Janet Fricker
  • 17 February 2025
View Post
  • News

OncoDaily Acquires CancerWorld: A New Era in Oncology Media

  • Christopher Greenberg
  • 22 January 2025
View Post
  • News

Second-generation BTK inhibitor shows promise as fixed-duration therapy in CLL

  • Janet Fricker
  • 18 December 2024
View Post
  • News

New evidence can help inform decisions on managing early-onset breast cancer linked to BRCA mutations

  • Janet Fricker
  • 18 December 2024
View Post
  • News

Gut microbiota influence effectiveness of tamoxifen in breast cancer

  • Janet Fricker
  • 6 December 2024
View Post
  • News

Radiotherapy prior to immunotherapy is the best treatment sequence for melanoma related brain metastases

  • Janet Fricker
  • 6 December 2024
View Post
  • News

Study helps solve the puzzle of checkpoint inhibitor myocarditis

  • Janet Fricker
  • 22 November 2024
View Post
  • News

Smoking cessation fundamental to first-line cancer care

  • Janet Fricker
  • 21 November 2024
search
or search in Cancerworld archive
Newsletter

Subscribe free to
Cancerworld!

We'll keep you informed of the latest features and news with a fortnightly email

Subscribe now
Latest News
  • Key link identified in mechanism promoting lung metastases from breast cancer
    • 17 February 2025
  • OncoDaily Acquires CancerWorld: A New Era in Oncology Media
    • 22 January 2025
  • Second-generation BTK inhibitor shows promise as fixed-duration therapy in CLL
    • 18 December 2024
  • New evidence can help inform decisions on managing early-onset breast cancer linked to BRCA mutations
    • 18 December 2024
  • Gut microbiota influence effectiveness of tamoxifen in breast cancer
    • 6 December 2024
Article
  • China’s integrated cancer care guidelines ‘reflect self-confidence’ in the field of oncology
    • 15 February 2025
  • Europe’s cancer agenda: how we keep it a priority in changing times
    • 20 December 2024
  • Humour: an essential tool in cancer care and communication
    • 18 December 2024
Social

Would you follow us ?

Contents
  • Stella Kyriakides: using her voice to improve health in Europe
    • 22 November 2024
  • Bulgarian oncologist Assia Konsoulova
    Assia Konsoulova: improving Bulgaria’s cancer system one oasis at a time
    • 8 November 2024
  • Mohit Singh and his mother Amrita: they are the protagonists of a long and ultimately unsuccessful journey across India in search of cures for her cancer
    ‘I feel guilty sometimes’: a young carer reflects on three years of a losing battle to save his mum
    • 24 October 2024
MENU
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
Cancerworld Magazine
  • About us
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy

Cancerworld is published by OncoDaily (P53 Inc.) | Mailing Address: 867 Boylston st, 5th floor, Ste 1094 Boston, MA 02116, United States | [email protected]

Archivio Cancerworld

Input your search keywords and press Enter.